Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up study*,**
References (22)
Long-term follow-up of polymyalgia rheumatica: evidence for synovitis
Semin Arthritis Rheum
(1984)- et al.
Polymyalgia rheumatica
Lancet
(1997) - et al.
Polymyalgia rheumatica
Lancet
(1996) - et al.
Acute phase proteins in the monitoring of inflammatory disorders
Baillieres Clin Rheumatol
(1994) - et al.
Giant cell arteritis: validity and reliability of various diagnostic criteria
Am J Ophthalmol
(1997) - et al.
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study
Ann Intern Med
(1982) - et al.
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow-up
Ann Reum Dis
(1989) - et al.
The erythrocyte sedimentation rate
Ann Intern Med
(1986) - et al.
The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome
Ann Rheum Dis
(1983) - et al.
Polymyalgia rheumatica in patients with a normal erythrocyte sedimentation rate
Arthritis Rheum
(1996)
Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate
Arch Intern Med
Cited by (165)
Polymyalgia rheumatica
2023, The LancetCurrent validity of the erythrocyte sedimentation rate
2023, Medicina Clinica[<sup>18</sup>F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects
2023, Seminars in Nuclear MedicineThe evaluation and treatment of autoimmune diseases
2022, Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic DiseasesFever of Unknown Origin in Adults
2022, American Family PhysicianA new dawn for polymyalgia rheumatica From diagnosis to emerging treatments
2024, Medicine Today
- *
Fabrizio Cantini, MD: Consultant, Director, Unità Reumatologica, 2nd Divisione di Medicina, Ospedale di Prato,Italy; Carlo Salvarani, MD: Consultant, Director, Unità Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy; Ignazio Olivieri, MD: Consultant, Director, Servizio di Reumatologia, Ospedale S. Carlo, Potenza, Italy; Luigi Macchioni, MD, Assistant, Unità Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy; Andrea Ranzi, PhD: Cattedra di Biometria e Statistica Medica, Istituto di Igiene, Università di Modena, Modena, Italy; Laura Niccoli, MD: Assistant, Unità Reumatologica, 2nd Divisione di Medicina, Ospedale di Prato, Prato, Italy; Angela Padula, MD: Assistant, Servizio di Reumatologia, Ospedale S.Carlo, Potenza, Italy; Luigi Boiardi, MD, PhD: Unità Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy.
- **
Address reprint requests to Fabrizio Cantini, MD, Unità Reumatologica, 2nd Divisione di Medicina, Ospedale di Prato, Piazza Ospedale No. 1, 59100 Prato, Italy. E-mail: fcantini@[email protected]